Recurrent Miscarriage: a Re- View
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Monosomy X Turner Syndrome Information for Patients
Monosomy X Turner syndrome Information for patients The healthcare professional responsible for your care has given you this leaflet because you have been identified by the Harmony® Prenatal Test as having a high probability of a chromosome disorder in your pregnancy. This fact sheet contains more information about the particular genetic disorder mentioned in your Harmony report. We recommend that you also discuss your result with an experienced doctor or genetic counsellor. Turner syndrome, or Monosomy X, is a sex chromosome disorder that occurs in females when there is only one copy of the X chromosome instead of the expected two (Figure 1). It occurs in at least one in every 2,500 female births. Monosomy X may be associated with an increased risk of miscarriage in the first or second trimester. More than half of those withT urner syndrome will be mosaic, meaning some of their cells have just one X chromosome and the other cells have two X chromosomes. Features and symptoms of Turner syndrome include subtle changes in physical appearance, short stature, infertility and learning difficulties, as well as some potential health conditions, including cardiac conditions, hypothyroidism, diabetes and autoimmune disease. Babies who are born with Turner syndrome could have a number of the features and symptoms of the syndrome, however, not everyone will have them all and severity will vary significantly. Mosaicism also plays a role in the varied severity of the syndrome. Although there is no cure for Turner syndrome, many of the associated symptoms can be treated. Girls with Turner syndrome may need regular health checks of their heart, kidneys and reproductive system throughout their lives. -
Adenomyosis in Infertile Women: Prevalence and the Role of 3D Ultrasound As a Marker of Severity of the Disease J
Puente et al. Reproductive Biology and Endocrinology (2016) 14:60 DOI 10.1186/s12958-016-0185-6 RESEARCH Open Access Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease J. M. Puente1*, A. Fabris1, J. Patel1, A. Patel1, M. Cerrillo1, A. Requena1 and J. A. Garcia-Velasco2* Abstract Background: Adenomyosis is linked to infertility, but the mechanisms behind this relationship are not clearly established. Similarly, the impact of adenomyosis on ART outcome is not fully understood. Our main objective was to use ultrasound imaging to investigate adenomyosis prevalence and severity in a population of infertile women, as well as specifically among women experiencing recurrent miscarriages (RM) or repeated implantation failure (RIF) in ART. Methods: Cross-sectional study conducted in 1015 patients undergoing ART from January 2009 to December 2013 and referred for 3D ultrasound to complete study prior to initiating an ART cycle, or after ≥3 IVF failures or ≥2 miscarriages at diagnostic imaging unit at university-affiliated private IVF unit. Adenomyosis was diagnosed in presence of globular uterine configuration, myometrial anterior-posterior asymmetry, heterogeneous myometrial echotexture, poor definition of the endometrial-myometrial interface (junction zone) or subendometrial cysts. Shape of endometrial cavity was classified in three categories: 1.-normal (triangular morphology); 2.- moderate distortion of the triangular aspect and 3.- “pseudo T-shaped” morphology. Results: The prevalence of adenomyosis was 24.4 % (n =248)[29.7%(94/316)inwomenaged≥40 y.o and 22 % (154/ 699) in women aged <40 y.o., p = 0.003)]. Its prevalence was higher in those cases of recurrent pregnancy loss [38.2 % (26/68) vs 22.3 % (172/769), p < 0.005] and previous ART failure [34.7 % (107/308) vs 24.4 % (248/1015), p < 0.0001]. -
Case-Scenario-10-FINAL.Pdf
Case scenario 10 – Magdalena Part 1 • Magdalena is 26 years old. She is 13 weeks pregnant and had a high chance combined test result of 1 in 140 for trisomy 13 with an NT measurement of 2.4mm. • After a lengthy discussion about her options, she decided to have NIPT. • The results reported a greater than 60% chance of the baby having Patau’s syndrome. She decided to have an invasive test. A CVS was performed. Would you have offered a CVS to this patient? a) No - she should be offered an amniocentesis only, due to the chance of placental factors affecting a result. b) Yes - the patient should be informed of risks and benefits of both CVS and amniocentesis. Answer b) Yes - the patient should be informed of the risks and benefits of a CVS and amniocentesis. Additional note A patient/couple should be informed of the options of both forms of diagnostic procedures. They should be informed of the benefits and limitations of each test, this should include timing of testing, possible results and risks of miscarriage. This discussion should also include the couples ethical, religious, social and individual beliefs. Name the type of mosaicism that can cause a false-positive result with NIPT. a) Feto-placental mosaicism b) Placental mosaicism c) Fetal mosaicism Answer b) Placental mosaicism Additional note There is a discrepancy of the cell line in the placenta and baby. The abnormal cell lines are seen in the placenta and not on the fetus. There is a small chance that a 'high chance report is caused by 'placental mosaicism', therefore a CVS may also report 'mosaicism’. -
The Role of Endometrial Stem Cells in Recurrent Miscarriage
REPRODUCTIONREVIEW Success after failure: the role of endometrial stem cells in recurrent miscarriage Emma S Lucas1,2, Nigel P Dyer3, Katherine Fishwick1, Sascha Ott2,3 and Jan J Brosens1,2 1Division of Biomedical Sciences, Warwick Medical School, Coventry, UK, 2Tommy’s National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK and 3Warwick Systems Biology Centre, University of Warwick, Coventry, UK Correspondence should be addressed to J Brosens; Email: [email protected] Abstract Endometrial stem-like cells, including mesenchymal stem cells (MSCs) and epithelial progenitor cells, are essential for cyclic regeneration of the endometrium following menstrual shedding. Emerging evidence indicates that endometrial MSCs (eMSCs) constitute a dynamic population of cells that enables the endometrium to adapt in response to a failed pregnancy. Recurrent miscarriage is associated with relative depletion of endometrial eMSCs, which not only curtails the intrinsic ability of the endometrium to adapt to reproductive failure but also compromises endometrial decidualization, an obligatory transformation process for embryo implantation. These novel findings should pave the way for more effective screening of women at risk of pregnancy failure before conception. Reproduction (2016) 152 R159–R166 Introduction Successful implantation of a human embryo is commonly date (Fragouli et al. 2013), each implanting blastocyst attributed to binary variables; i.e. nidation of a ‘normal’, is arguably unique. Furthermore, transient aneuploidy but not an ‘abnormal’, embryo in a ‘receptive’, but during development may not be unequivocally as not a ‘non-receptive’, endometrium is required for ‘bad’ as has been intuitively presumed because of the a successful pregnancy. -
Chromosome 18
Chromosome 18 Description Humans normally have 46 chromosomes in each cell, divided into 23 pairs. Two copies of chromosome 18, one copy inherited from each parent, form one of the pairs. Chromosome 18 spans about 78 million DNA building blocks (base pairs) and represents approximately 2.5 percent of the total DNA in cells. Identifying genes on each chromosome is an active area of genetic research. Because researchers use different approaches to predict the number of genes on each chromosome, the estimated number of genes varies. Chromosome 18 likely contains 200 to 300 genes that provide instructions for making proteins. These proteins perform a variety of different roles in the body. Health Conditions Related to Chromosomal Changes The following chromosomal conditions are associated with changes in the structure or number of copies of chromosome 18. Distal 18q deletion syndrome Distal 18q deletion syndrome occurs when a piece of the long (q) arm of chromosome 18 is missing. The term "distal" means that the missing piece (deletion) occurs near one end of the chromosome arm. The signs and symptoms of distal 18q deletion syndrome include delayed development and learning disabilities, short stature, weak muscle tone ( hypotonia), foot abnormalities, and a wide variety of other features. The deletion that causes distal 18q deletion syndrome can occur anywhere between a region called 18q21 and the end of the chromosome. The size of the deletion varies among affected individuals. The signs and symptoms of distal 18q deletion syndrome are thought to be related to the loss of multiple genes from this part of the long arm of chromosome 18. -
Female Fertility Assessment
Assessment Female Fertility Assessment Fertility challenges impact millions of couples in the United States and Medical conditions that impact the function of a woman’s ovaries, fallopian around the globe. Approximately 10% of US women ages 15-44 have tubes, or uterus can contribute to female infertility. Anovulation causes can difficulty getting or staying pregnant.1 Infertility is defined as the inability to include underweight, overweight/obesity, PCOS, endometriosis, diminished get pregnant after one year of trying (or six months in a woman 35 years or ovarian reserve (e.g., due to age), functional hypothalamic amenorrhea older) through unprotected sex.2 In addition to age and coital frequency,3 (FHA), dysfunction of the hypothalamus or pituitary gland, premature hormonal health has a major physiological influence on fertility. ovarian insufficiency, and menopause.2,13 In women, ovulation depends on a regular menstrual cycle, a 28-day Reproductive endocrinologists specialize in infertility and also support symphony of the hypothalamic-pituitary-gonadal (HPG) axis involving women who have experienced recurrent pregnancy loss; however, a specific fluctuations in estrogen and progesterone levels, shown in the multidisciplinary clinical team approach addressing hormonal, lifestyle, Figures in this assessment.4,5 The pituitary gland sends pulses of follicle- social support, and other factors is ideal. While this clinical tool focuses stimulating hormone (FSH) in the follicular phase (days 1-14), triggering on female fertility, it is important to point out that approximately 40% the rise of estrogen, which stimulates the hypothalamic release of of fertility cases involve a male factor (e.g., low sperm count or quality).3 gonadotropin-releasing hormone (GnRH), causing the pituitary secretion Thus, a couple’s approach to fertility assessment is prudent to uncover and of luteinizing hormone (LH).4,5 FSH and LH surges result in egg release from address underlying root causes preventing conception. -
22Q13.3 Deletion Syndrome
22q13.3 deletion syndrome Description 22q13.3 deletion syndrome, which is also known as Phelan-McDermid syndrome, is a disorder caused by the loss of a small piece of chromosome 22. The deletion occurs near the end of the chromosome at a location designated q13.3. The features of 22q13.3 deletion syndrome vary widely and involve many parts of the body. Characteristic signs and symptoms include developmental delay, moderate to profound intellectual disability, decreased muscle tone (hypotonia), and absent or delayed speech. Some people with this condition have autism or autistic-like behavior that affects communication and social interaction, such as poor eye contact, sensitivity to touch, and aggressive behaviors. They may also chew on non-food items such as clothing. Less frequently, people with this condition have seizures or lose skills they had already acquired (developmental regression). Individuals with 22q13.3 deletion syndrome tend to have a decreased sensitivity to pain. Many also have a reduced ability to sweat, which can lead to a greater risk of overheating and dehydration. Some people with this condition have episodes of frequent vomiting and nausea (cyclic vomiting) and backflow of stomach acids into the esophagus (gastroesophageal reflux). People with 22q13.3 deletion syndrome typically have distinctive facial features, including a long, narrow head; prominent ears; a pointed chin; droopy eyelids (ptosis); and deep-set eyes. Other physical features seen with this condition include large and fleshy hands and/or feet, a fusion of the second and third toes (syndactyly), and small or abnormal toenails. Some affected individuals have rapid (accelerated) growth. -
Survivors of Acute Leukemia Are Less Likely to Have Liveborn Infants Than Are Their
CHILDHOOD CANCER SURVIVOR STUDY ANALYSIS PROPOSAL STUDY TITLE: Fertility Rates in Long-Term Survivors of Acute Lymphoblastic Leukemia WORKING GROUP AND INVESTIGATORS: Name Telephone Number E-mail Daniel M. Green, M.D. 901-595-5915 [email protected] Vikki Nolan, Ph.D. 901-595-6078 [email protected] Liang Zhu, Ph.D. 901-595-5240 [email protected] Marilyn Stovall, Ph.D. 713-792-3240 [email protected] Sarah Donaldson, M.D. 650-723-6195 [email protected] Les Robison, Ph.D. 901-595-5817 [email protected] Chuck Sklar, M.D. 212-717-3239 [email protected] BACKGROUND AND RATIONALE: Survivors of acute leukemia are less likely to have liveborn infants than are their female siblings (relative risk (RR) =0.63, 95% confidence interval (CI) 0.52 to 0.76). The risk of miscarriage was increased among Childhood Cancer Survivor Study (CCSS) female participants who received craniospinal (RR=2.22, 95% CI 1.36 to 3.64) or cranial irradiation (RR=1.40, 95% CI 1.02 to 1.94). The risk of miscarriage was increased in survivors of acute lymphoblastic leukemia (ALL) (RR=1.60, 95% CI 0.85 to 3.00) and central nervous system tumors (RR=1.33, 95% CI 0.61 to 2.93) although neither risk achieved statistical significance 1. Winther et al. reported that the risk of spontaneous 2 abortion was not increased in survivors of leukemia compared to their sisters (proportion ratio (PR) 1.2, 95% CI 0.7 to 2.0). However those female survivors who received low doses of radiation to the uterus and ovaries, but high doses of radiation to the pituitary had an increased risk of spontaneous abortion (PR 1.8, 95% CI 1.1 to 3.0). -
Prevalence Along with Diagnostic Modalities and Treatment of Female Infertility Due to Female Genital Disorders
Virology & Immunology Journal MEDWIN PUBLISHERS ISSN: 2577-4379 Committed to Create Value for Researchers Prevalence Along with Diagnostic Modalities and Treatment of Female Infertility Due to Female Genital Disorders Omer Iqbal1 and Faiza Naeem2* Research Article 1College of Medicine and Pharmacy, Ocean University of China Qingdao, Shandong province, Volume 4 Issue 3 China Received Date: August 16, 2020 2Institute of Pharmacy, Lahore College for Women University, Pakistan Published Date: September 08, 2020 DOI: 10.23880/vij-16000249 *Corresponding author: Faiza Naeem, Institute of Pharmacy, Lahore College for Women University, Lahore, Pakistan, Email: [email protected] Abstract Infertility is a communal pathological ailment now-a-days worldwide and approximately females are mostly suffering from this condition. In previous studies, out of 2.4 million married couples have females in between the ages from 15-44 year; 1.0 million couples were suffering from primary infertility and 1.4 million couples had secondary infertility. The infertility causes are ovulatory factors, dietary factors, psychological factors, abnormal endocrine functions, fallopian tube disorders etc. PCOS, PIDs, endometriosis. The ultrasonography is the most powerful tool for diagnosis. The treatment involves medical, surgical and assisted reproduction. Medical treatment includes clomiphene, metformin, iron & folic acid supplements along with oral- contraceptives. Surgical treatment is operative laparoscopy and assisted reproduction is achieved by IVF, GIFT & IUI etc. It is concluded from the study that the percentage prevalence of female infertility among ages was higher in age group (25-34) years (76%) and it was mostly secondary infertility (54%). The main pathological factor of female infertility in Sialkot city was PCOS, which was 52% of evaluated patients. -
Role of Maternal Age and Pregnancy History in Risk of Miscarriage
RESEARCH Role of maternal age and pregnancy history in risk of BMJ: first published as 10.1136/bmj.l869 on 20 March 2019. Downloaded from miscarriage: prospective register based study Maria C Magnus,1,2,3 Allen J Wilcox,1,4 Nils-Halvdan Morken,1,5,6 Clarice R Weinberg,7 Siri E Håberg1 1Centre for Fertility and Health, ABSTRACT Miscarriage and other pregnancy complications might Norwegian Institute of Public OBJECTIVES share underlying causes, which could be biological Health, PO Box 222 Skøyen, To estimate the burden of miscarriage in the conditions or unmeasured common risk factors. N-0213 Oslo, Norway Norwegian population and to evaluate the 2MRC Integrative Epidemiology associations with maternal age and pregnancy history. Unit at the University of Bristol, Introduction Bristol, UK DESIGN 3 Miscarriage is a common outcome of pregnancy, Department of Population Prospective register based study. Health Sciences, Bristol Medical with most studies reporting 12% to 15% loss among School, Bristol, UK SETTING recognised pregnancies by 20 weeks of gestation.1-4 4Epidemiology Branch, National Medical Birth Register of Norway, the Norwegian Quantifying the full burden of miscarriage is Institute of Environmental Patient Register, and the induced abortion register. challenging because rates of pregnancy loss are Health Sciences, Durham, NC, USA PARTICIPANTS high around the time that pregnancies are clinically 5Department of Clinical Science, All Norwegian women that were pregnant between recognised. As a result, the total rate of recognised University of Bergen, Bergen, 2009-13. loss is sensitive to how early women recognise their Norway pregnancies. There are also differences across countries 6 MAIN OUTCOME MEASURE Department of Obstetrics and studies in distinguishing between miscarriage and and Gynecology, Haukeland Risk of miscarriage according to the woman’s age and University Hospital, Bergen, pregnancy history estimated by logistic regression. -
Genetic Counseling and Diagnostic Guidelines for Couples with Infertility And/Or Recurrent Miscarriage
medizinische genetik 2021; 33(1): 3–12 Margot J. Wyrwoll, Sabine Rudnik-Schöneborn, and Frank Tüttelmann* Genetic counseling and diagnostic guidelines for couples with infertility and/or recurrent miscarriage https://doi.org/10.1515/medgen-2021-2051 to both partners prior to undergoing assisted reproduc- Received January 16, 2021; accepted February 11, 2021 tive technology. In couples with recurrent miscarriages, Abstract: Around 10–15 % of all couples are infertile, karyotyping is recommended to detect balanced structural rendering infertility a widespread disease. Male and fe- chromosomal aberrations. male causes contribute equally to infertility, and, de- Keywords: female infertility, male infertility, miscarriages, pending on the defnition, roughly 1 % to 5 % of all genetic counseling, ART couples experience recurrent miscarriages. In German- speaking countries, recommendations for infertile cou- ples and couples with recurrent miscarriages are pub- lished as consensus-based (S2k) Guidelines by the “Ar- Introduction beitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften” (AWMF). This article summarizes the A large proportion of genetic consultation appointments current recommendations with regard to genetic counsel- is attributed to infertile couples and couples with recur- ing and diagnostics. rent miscarriages. Infertility, which is defned by the WHO Prior to genetic counseling, the infertile couple as the inability to achieve a pregnancy after one year of must undergo a gynecological/andrological examination, unprotected intercourse [1], afects 10–15 % of all couples, which includes anamnesis, hormonal profling, physical thus rendering infertility a widespread disease, compara- examination and genital ultrasound. Women should be ex- ble to, e. g., high blood pressure or depression. Histori- amined for the presence of hyperandrogenemia. Men must cally, the female partner has been the focus of diagnos- further undergo a semen analysis. -
Chromosome Abberrations N Genetic Diseases
Chromosomal Analysis Dr. Monisha Banerjee Professor Molecular & Human Genetics Laboratory Department of Zoology University of Lucknow Lucknow-226007 Chromosome Morphology Telomere Short arm (p) Centromere Arm Long arm (q) Telomere Metacentric Submetacentric Acrocentric Defining Chromosomal Location Arm Region Band Subband 3 2 2 1 2 2 p 1 1 5 1 4 1 3 2 1 1 2 17 q 1 1 . 2 1 1 3 1 2 2 q 3 1 3 2, 3 4 2 1 4 2 Chromosome 17 3 Nomenclature system Visualizing Metaphase Chromosomes • Patient cells are incubated and divide in tissue culture. • Phytohemagglutinin (PHA): stimulates cell division. • Colcemid: arrests cells in metaphase. • 3:1 Methanol:Acetic Acid: fixes metaphase chromosomes for staining. Visualizing Metaphase Chromosomes (Banding) • Giemsa-, reverse- or centromere-stained metaphase chromosomes G-Bands R-Bands C-Bands Karyotype • International System for Human Cytogenetic Nomenclature (ISCN) – 46, XX – normal female – 46, XY – normal male • G-banded chromosomes are identified by band pattern. Normal Female Karyotype (46, XX) (G Banding) Types of Chromosomal Aberrations Numerical Abnormalities Structural Abnormalities Aneuploidy Aneuploidy occurs when one of the chromosomes is present in an abnormal number of copies. Trisomy and monosomy are two forms of aneuploidy. Chromosome Number Abnormality Aneuploidy (48, XXXX) Chromosome Number Abnormality Trisomy 21 (47, XX, +21) Down Syndrome is Caused by Trisomy for Chromosome 21 Aneuploidy is remarkably common, causing termination of at least 25% of human conceptions. Aneuploidy is also a driving force in cancer progression (virtually all cancer cells are aneuploid). Chromosome Non-Disjunction in Meiosis Causes Aneuploidy The Frequency of Chromosome Non-Disjunction And Down Syndrome Rises Sharply with Maternal Age Chromosome Number Abnormality Trisomy 13 (47, XX, +13) Trisomy 18 (47, XY,+18) Sex Chromosome Aneuploid Conditions are Common Klinefelter syndrome Polyploidy Polyploidy occurs when all the chromosomes are present in three or more copies.